Literature DB >> 3224765

Increased phospholipase A2 activity of Ileal mucosa in Crohn's disease.

G Olaison1, R Sjödahl, C Tagesson.   

Abstract

The activity of phospholipase A2 (EC 3.1.1.4) in endoscopic biopsy specimens of intestinal mucosa was compared in patients with Crohn's disease and controls without inflammatory bowel disease. In postresection Crohn patients there was significantly enhanced phospholipase A2 activity proximal to the anastomosis in the neoterminal ileum, whether or not the mucosa was inflamed at the time of biopsy. Highly elevated ileal phospholipase A2 activity had a predictive value for symptomatic relapse within 1 year after resection. Patients with concomitant Crohn's colitis, in whom the risk of ileal recurrence is particularly high, had greater ileal phospholipase A2 activity than noncolitis Crohn patients. Association thus was demonstrated between activity of phospholipase A2 in ileal mucosa and proneness to ileal inflammation in Crohn's disease.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3224765     DOI: 10.1159/000199765

Source DB:  PubMed          Journal:  Digestion        ISSN: 0012-2823            Impact factor:   3.216


  9 in total

1.  Raised serum activity of phospholipase A2 immunochemically related to group II enzyme in inflammatory bowel disease: its correlation with disease activity of Crohn's disease and ulcerative colitis.

Authors:  T Minami; H Tojo; Y Shinomura; S Tarui; M Okamoto
Journal:  Gut       Date:  1992-07       Impact factor: 23.059

2.  Increased production of tumour necrosis factor-alpha interleukin-1 beta, and interleukin-6 by morphologically normal intestinal biopsies from patients with Crohn's disease.

Authors:  J M Reimund; C Wittersheim; S Dumont; C D Muller; J S Kenney; R Baumann; P Poindron; B Duclos
Journal:  Gut       Date:  1996-11       Impact factor: 23.059

3.  Phospholipase A2 gene expression and activity in histologically normal ileal mucosa and in Crohn's ileitis.

Authors:  I Lilja; K Smedh; G Olaison; R Sjödahl; C Tagesson; C Gustafson-Svärd
Journal:  Gut       Date:  1995-09       Impact factor: 23.059

4.  Effects of endotoxin and dexamethasone on group I and II phospholipase A2 in rat ileum and stomach.

Authors:  I Lilja; J Dimberg; R Sjödahl; C Tagesson; C Gustafson-Svärd
Journal:  Gut       Date:  1994-01       Impact factor: 23.059

5.  Increased phospholipase A2 activity in peritoneal leukocytes in rat experimental colitis.

Authors:  S N Murthy; R J Biondi
Journal:  Inflammation       Date:  1992-06       Impact factor: 4.092

6.  Raised concentrations of platelet activating factor in colonic mucosa of Crohn's disease patients.

Authors:  I Sobhani; S Hochlaf; Y Denizot; C Vissuzaine; E Rene; J Benveniste; M M Lewin; M Mignon
Journal:  Gut       Date:  1992-09       Impact factor: 23.059

7.  PAF-acether and acetylhydrolase in stool of patients with Crohn's disease.

Authors:  Y Denizot; S Chaussade; N Nathan; J F Colombel; M J Bossant; N Cherouki; J Benveniste; D Couturier
Journal:  Dig Dis Sci       Date:  1992-03       Impact factor: 3.199

8.  Glucocorticoid treatment in ileal Crohn's disease: relief of symptoms but not of endoscopically viewed inflammation.

Authors:  G Olaison; R Sjödahl; C Tagesson
Journal:  Gut       Date:  1990-03       Impact factor: 23.059

9.  Increased group II phospholipase A2 in colonic mucosa of patients with Crohn's disease and ulcerative colitis.

Authors:  T Minami; H Tojo; Y Shinomura; Y Matsuzawa; M Okamoto
Journal:  Gut       Date:  1994-11       Impact factor: 23.059

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.